Bria, Pietro
 Distribuzione geografica
Continente #
EU - Europa 5.031
NA - Nord America 4.192
AS - Asia 1.027
AF - Africa 25
SA - Sud America 22
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 7
Totale 10.317
Nazione #
US - Stati Uniti d'America 4.148
DE - Germania 2.054
SE - Svezia 720
CN - Cina 671
IT - Italia 625
UA - Ucraina 597
FR - Francia 273
GB - Regno Unito 217
IE - Irlanda 195
SG - Singapore 128
FI - Finlandia 125
RU - Federazione Russa 103
IN - India 89
TR - Turchia 45
CA - Canada 30
BE - Belgio 24
PL - Polonia 23
JP - Giappone 21
CI - Costa d'Avorio 20
IR - Iran 17
NL - Olanda 17
BR - Brasile 16
VN - Vietnam 15
AU - Australia 13
ES - Italia 13
MX - Messico 13
KR - Corea 12
CH - Svizzera 8
HK - Hong Kong 7
RO - Romania 5
BG - Bulgaria 4
BY - Bielorussia 4
EG - Egitto 4
LT - Lituania 4
NO - Norvegia 4
TW - Taiwan 4
A1 - Anonimo 3
AT - Austria 3
CL - Cile 3
CZ - Repubblica Ceca 3
HU - Ungheria 3
IL - Israele 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
BD - Bangladesh 2
EU - Europa 2
HR - Croazia 2
ID - Indonesia 2
MC - Monaco 2
MY - Malesia 2
RS - Serbia 2
DZ - Algeria 1
IQ - Iraq 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MM - Myanmar 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
Totale 10.317
Città #
Chandler 861
Jacksonville 327
Ashburn 283
San Mateo 245
Dublin 191
Nanjing 181
Wilmington 156
Milan 124
Nürnberg 124
Dearborn 120
Woodbridge 119
Bremen 106
Houston 90
Redwood City 90
Singapore 86
New York 85
Rome 78
Ann Arbor 77
Nanchang 77
Boston 75
Seattle 70
Lawrence 68
Moscow 65
Beijing 53
University Park 53
Princeton 48
Marseille 47
Norwalk 45
Mountain View 44
Munich 42
Lancaster 40
Fairfield 36
Hebei 33
Cattolica 31
Kunming 30
Guangzhou 27
Shenyang 27
Cambridge 26
Fremont 25
Hangzhou 25
Izmir 25
Tianjin 25
Changsha 22
Falls Church 22
Kraków 22
Boardman 21
Abidjan 20
Andover 20
Dallas 18
Philadelphia 18
Shanghai 18
Brussels 17
Menlo Park 17
Jiaxing 16
Los Angeles 16
Columbus 15
Hanoi 14
Hefei 14
Pune 14
Saint-Ouen-l'Aumone 13
Detroit 12
Augusta 11
Atlanta 10
Bologna 10
Kish 10
Leawood 10
Simi Valley 10
Helsinki 9
Lanzhou 9
Guidonia 8
Edinburgh 7
Paris 7
Ankara 6
Bari 6
Changchun 6
Chicago 6
Indiana 6
Jinan 6
Acton 5
Alzate Brianza 5
Busto Arsizio 5
Como 5
Evanston 5
Florence 5
Kocaeli 5
London 5
Nola 5
Saint Petersburg 5
Zhengzhou 5
Cagliari 4
Costa Mesa 4
Cuauhtémoc 4
Genoa 4
Groningen 4
Hong Kong 4
Kenosha 4
Oslo 4
Ottawa 4
Phoenixville 4
Tavazzano 4
Totale 4.945
Nome #
Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial 202
Plasma cortisol levels and resilience in depressed patients 186
Bipolar Disorder Questionnaire for the Assessment of Learning: a New Instrument for Studying Information Acquisition in Psychoeducational programs. 167
Behavioural addictions in bipolar disorder patients: Role of impulsivity and personality dimensions 161
Programma di trattamento integrato in regime di day hospital per pazienti depressi “difficili” da trattare. 156
Neuroendocrinologia dei disturbi dell umore 149
Dopamine transporter availability and psychomotor retardation in major depression 148
Alterazioni delle risposte immuno-infiammatorie nei pazienti affetti da disturbo depressivo maggiore (Immune-inflammatory response changes in patients with major depressive disorder) 147
Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial. 146
Plasma magnesium level and psychomotor retardation in major depressed patients 137
Problematic mobile phone use in adolescence: A cross-sectional study 135
A day treatment programme on mood disorders: One-year activity outcomes 131
Augmentation of drug treatment with bright light therapy in patients with difficult-to-treat depression: acute and long term observation 130
Sexual Behavior in Women with Bipolar Disorder 127
Non-Epileptic Seizures (NES) are predicted by depressive and dissociative symptoms 126
Striatal dopamine transporter (DAT) availability and affective symptoms in movement disorders: a 123I-FP-CIT SPECT study. 124
[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study] 123
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up. 123
Internet addiction: hours spent online, behaviors and psychological symptoms 118
Predicting treatment outcome in difficult-to-treat depressed patients 118
Plasma magnesium levels and treatment outcome in depressed patients 115
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up 110
[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study]. 108
Role of Substance Abuse Comorbidity and Personality on the Outcome of Depression in Bipolar Disorder: Harm Avoidance Influences Medium-Term Treatment Outcome. 107
Plasma magnesium levels and treatment outcome in depressed patients 107
Correlations Between Striatal Dopamine Transporter (DAT) Availability and Psychiatric Symptoms in Movement Disorders: A 123I-FP-CIT SPECT Study. 107
Modulation of motor cortex neuronal networks by rTMS: comparison of local and remote effects of six different protocols of stimulation 106
Factors associated with the course of symptoms in bipolar disorder during a 1-year follow-up: depression vs. sub-threshold mixed state 105
An observational study evaluating comorbidity between bipolar disorder and personality disorders 104
Behavioural addictions in adolescents and young adults: results from a prevalence study. 104
Il trattamento della schizofrenia 104
Alcohol protracted withdrawal syndrome: the role of anhedonia 103
Changing of dopamine transporter binding in depressed patients with anhedonia during treatment 102
Affective temperament and attachment in adulthood in patients with Bipolar Disorder and Cyclothymia 102
Changes of Dopamine Transporter Availability in Depressed Patients with and without Anhedonia: A 123I-N-ω-Fluoropropyl-Carbomethoxy-3β-(4-Iodophenyl)tropane SPECT Study 102
Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up 101
Role of substance abuse comorbidity and personality on the outcome of depression in bipolar disorder: harm avoidance influences medium-term treatment outcome 100
Anhedonia and Cortisol Levels in Major Depression. 100
Polysomnographic Findings in a Cohort of Chronic Insomnia Patients with Benzodiazepines Abuse 100
Cognitive markers of psychotic unipolar depression: A meta-analytic study 100
The assessment of post-detoxification anhedonia: influence of clinical and psychosocial variables 99
Treatment of prurigo nodularis with pregabalin. 99
Affective temperaments and psychopathological dimensions of personality in bipolar and cyclothymic patients 95
Treatment of prurigo nodularis with pregabalin 94
Augmentation of light therapy in difficult-to-treat depressed patients: an open-label trial in both unipolar and bipolar patients 94
Predictive value of magnesium levels in depressed patients. 93
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up 93
Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome. 92
Psicopatologia nell’epilessia e nella pseudoepilessia: risultati preliminari nella nostra esperienza 92
Clinical correlates of difficult-to-treat depression: Exploring an integrated day-care model of treatment 92
Affective temperaments and psychopathological dimensions of personality in Bipolar Disorder 90
Striatal dopamine transporter density in anhedonic depressed patients before and after pharmachological treatment 88
Somatic symptoms and high-sensitive C-reactive protein in major depression 87
Ansia, depressione ed epilessia del lobo temporale 84
Depression and suicide in epilepsy: Fact or artefact? 84
SNRI effective treatment does not restore changes of immune and inflammatory parameters in depressed patients 84
Plasma dehydroepiandrosterone sulphate (DHEAS) and cortisol in patients with mood disorders 84
Oxcarbazepine in bipolar disorder: a critical review of the literature 83
La gestione della crisi suicidaria: dall'emergenza clinica alla riabilitazione del paziente 82
Facial emotion recognition deficit in Amnestic Mild Cognitive Impairment and Alzheimer Disease 82
Inflammatory response and psychopathological dimensions in major depression 81
Mood, hormones and quality of life. 80
Hyperactivation of inflammatory response in depressed patients with psychomotor retardation 80
Antidepressant treatment restores brain-derived neurotrophic factor serum levels and ameliorates motor function in Parkinson disease patients 80
Major depressive disorder and dopamine transporter density: investigation by 123I-FP-CIT SPET 80
What is the effect of selective serotonin reuptake inhibitors on temperament and character in patients with fibromyalgia? 79
Duloxetine for premenstrual dysphoric disorder: a pilot study 79
Cocaine use disorders and serum magnesium profile 79
Reply to Dr Corrao and colleagues. 77
Oxcarbazepine improves mood in patients with epilepsy. 77
Oxcarbazepine improves mood in patients with epilepsy 77
Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study. 77
Behavioural addictions in adolescents and young adults: results from a prevalence study 77
Enhanced BDNF serum levels in patients with severe pathological gambling 76
Sleep Disturbances and Depression: a review 74
Venlafaxine: Successful treatment in impulsive disorders 74
Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusers 74
Plasma levels of n-3 fatty acids in bipolar patients: Deficit restricted to DHA 74
Enhanced BDNF serum levels in patients with severe pathological gambling 74
Reply to Dr Korczyn. 72
To be or not to be a bipolar disorder patient: problems with diagnosis. 72
Cognitive markers of psychotic unipolar depression: A meta-analytic study 71
Neuroendocrinology of mood disorders. 69
Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview. 69
Bipolar disorder and epilepsy: a bidirectional relation? Neurobiological underpinnings, current hypotheses, and future research directions 69
Effects of psychostimulants on neurotrophins implications for psychostimulant-induced neurotoxicity. 68
Evidenze preliminari sulle modifiche del transporter della dopamina in pazienti depressi con rallentamento psicomotorio 68
Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview 67
DAT binding and psychopathological features in depressed patients. 66
Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: An overview. 66
Chronic ketamine use increases serum levels of brain-derived neurotrophic factor. 65
Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding 64
Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms 64
Poprawa nastroju u chorych na padaczke leczonych okskarbazepina 63
Il self-help nelle condizioni depressive: analisi dell esperienza di un gruppo di mutuo-aiuto per pazienti depressi in remissione parziale. 62
Analisi antropofenomenologica di un'esperienza in un'istituzione manicomiale del meridione 62
Paliperidone for treatment of obsessive compulsive resistant symptoms in schizophrenia: a case report. 61
Functional neuroimaging: points of intersection between biology and psychotherapy. 60
Primary cerebral blood flow deficiency and Alzheimer's disease: shadows and lights. 60
Valutazione dell esperienza di un gruppo di self-help in pazienti depressi in remissione parziale. 57
Totale 9.576
Categoria #
all - tutte 33.571
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.571


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.347 265 97 100 55 87 82 180 46 65 43 179 148
2020/20211.260 54 123 29 132 181 67 231 16 137 92 178 20
2021/20221.102 109 135 19 61 40 26 34 193 40 70 169 206
2022/20232.407 297 362 160 409 196 273 121 161 297 22 74 35
2023/20241.003 48 303 23 44 37 112 42 34 35 51 154 120
2024/202581 81 0 0 0 0 0 0 0 0 0 0 0
Totale 10.376